Barclays PLC Cara Therapeutics, Inc. Put Options Transaction History

Barclays PLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 May 15, 2019	SELL	$14.41 - $19.64 $11,528 - $15,712	-800 Reduced 66.67%	400 $8,000
Q3 2018 Nov 14, 2018	SELL	$17.57 - $23.95 $1.53 Million - $2.09 Million	-87,300 Reduced 98.64%	1,200 $29,000
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $1.03 Million - $1.71 Million	88,500 New	88,500 $1.7 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.